MSD repurposing dormant Irish site and hiring 350 to support Keytruda
Merck Sharp & Dohme (MSD) plans to build a biologics facility at a former small molecule manufacturing site in Swords, Ireland, which it closed last year.
Archives for February 14, 2018
Sanofi looks to cell culture tech for universal flu vaccine
Sanofi Pasteur has licensed SK Chemicals' mammalian cell culture platform for vaccine production in a deal worth up to $155m (€126m).
Cellectis wins patents for CRISPR gene editing in T-cells
The French allogeneic T-cell developer says CRISPR/Cas9 technology is an “easy-to-use and cheap tool” for gene editing and plans to license the patents to others.